01 · Phase 1Build & Operate
Phase 1
Team-built Mazzaneh product and market execution.
- Real product modules
- Users, sellers and businesses
- Commerce and analytics loops
- External product-program recognition
MZN · Multi-Phase Technology & AI Portfolio
From Product Execution to AI-Native Asset Formation — and into Independent Validation.
Build. Form. Validate — without collapsing the boundaries.
MZN connects a team-built product and market foundation, a later solo AI-native formation period, and a Phase 3 pathway for independent review, validation and commercialization.
Phase separation is part of the claim architecture — not presentation styling.
01 · Start with the question
Do not read MZN linearly.
Start with the object you actually need to understand. The site routes product, technical, research, partnership and OPU questions to different evidence and review paths.
01 · Orientation
Understand MZN
Company architecture, chronology, portfolio logic and the correct way to enter the review system.
Start with MZN →
02 · Product / Market
Review Phase 1
Mazzaneh, real product mechanisms, sellers, buyers, commerce, analytics and operating history.
Open Phase 1 →
03 · Technical
Explore the Portfolio
Tokenizer, GPU, LLM systems, security, research and architecture routes with separate maturity states.
Open Portfolio →
04 · Research
Review Research
BioCode, HDTP, ISBP and selected foundational, protocol and security research.
Open Research →
05 · Phase 3
Assess Partnership Fit
Choose a program, asset or cluster first — then define diligence, integration and commercial terms.
Open Partnership →
06 · Separate Case
Evaluate the OPU Case
Test the bounded Phase 2 provenance case independently from the wider company and Phase 3 story.
Open OPU →02 · The phase architecture
Three phases. Three different questions.
Chronology, provenance, maturity and current program status are kept separate so later work does not rewrite earlier history.
01 · Phase 1
02 · Phase 2Form & Architect
Phase 2
Closed bounded solo AI-native formation period.
- 330+ mapped assets & sub-assets
- Technical, research and security systems
- Implemented / internally tested assets
- OPU provenance boundary
03 · Phase 3Validate & Advance
Phase 3
Open modular advancement layer.
- Mazzaneh re-launch
- HUAI and Zoyan programs
- Standalone asset / cluster paths
- OPU review and category advancement
03 · What is actually being reviewed
One portfolio. Different evidence objects.
A commerce system, a tokenizer, a security threat-discovery asset, a research framework and a Phase 3 product program should not be judged with the same evidence standard.
01↗
02↗
03↗
04↗
05↗
06↗
07↗
Product & Commerce Systems
Mazzaneh · demand · seller workflows · attention · analytics · commerce outcomes
AI Infrastructure & Model Systems
Tokenizer · GPU · LLM architecture · routing · memory · optimization
Security, Trust & Boundary Systems
ZOE · ISBP · safety/control · monitoring · permission boundaries
Human-Context Intelligence
HUAI · signal provenance · confidence · context · memory · permission · consequence
Foundational & Applied Research
BioCode · HDTP · ISBP · human grounding · protocol and security research
Product & Convergence Architecture
Zoyan · human-facing intelligence · optional HUAI / Mazzaneh / system integration
Review, Provenance & IP Architecture
Claim boundaries · review methodology · candidate IP · controlled diligence routes
04 · Technical signal
Depth without pretending everything is at the same maturity.
The portfolio includes implemented systems, internal tests, architecture candidates, research programs and reference maps. Phase 3 decides what deserves independent replication, productization or partnership.
330+Mapped Phase 2 assets & sub-assets — not finished products.
21LLM Anatomy capability slots across five major groups.
554Total canonical LLM Anatomy nodes — 21 roots + 533 descendants.
Representation
Tokenizer
Language and multimodal infrastructure with implementation and internal testing.
Open Tokenizer →05 · Architecture over inventory
Standalone value and integration value can coexist.
MZN is not one pipeline in which every asset must terminate in one product. Assets can stand alone, form clusters, enter independent partnerships or converge into larger systems when useful.
Phase 1
Product and market context
Mazzaneh provides operating history, commerce mechanisms and human/market signal lineage.
Phase 2
AI-native systems and research
Technical, security, evaluation and research assets retain independent maturity and provenance.
Phase 3
Select what deserves advancement
Validate, rebuild, pilot, license, partner, commercialize, integrate — or stop — at the relevant object level.
06 · Review discipline
Documentation, disclosure and validation are different layers.
The public site is designed for inspectability, not exhaustive disclosure. A serious review should know what is visible now, what can be inspected more deeply, and what still requires independent testing.
Public review surface
Concise pages define the claim, chronology, architecture, maturity and boundaries.
Public evidence
Linked records provide representative support, provenance signals and reviewable examples.
Controlled evidence
Security, IP, privacy, implementation and sensitive provenance can require staged or NDA review.
Independent validation
Replication, benchmarks, specialist review, legal/IP work and pilots remain separate from internal evidence.
Public incompleteness is not evidence of absence.Not every source file, test record or sensitive mechanism belongs on the open web.
Restricted evidence is not independent validation.Private material can support scope or provenance without becoming externally verified.
How to review the Founder case →Evidence Hub →Review & Diligence →Evaluation Protocol →LLM Capability Review PDF →
Challenge the map. Ask for the evidence.If a capability, maturity level or chronology point is not fully reproduced on this surface, request the relevant evidence route. Review can expand from representative material to the full relevant corpus under controlled access.
External signal, not proof.Founder-reported Crunchbase history shows sustained Top-10 visibility from May 2026 through this review period, with #1–#2 global observations in AI, Machine Learning and Cybersecurity. Dated screenshots are retained; the signal does not validate technical claims.
09 · Professional routes
Different evaluators should enter through different evidence.
The landing page does not force one universal order. It sends each evaluator to the review object closest to their actual role.
Commercial lens
Investors
Portfolio · Phase 3 · capital / transaction fit
Open route →
Engagement lens
Strategic Partners
Program / asset selection · diligence · pilot · terms
Open route →
Research lens
Researchers
BioCode · HDTP · ISBP · validation questions
Open route →
Technical lens
Technical Reviewers
LLM Anatomy · Tokenizer · GPU · security · optimization
Open route →
Review lens
IP / Legal
Provenance · candidate IP · disclosure · Phase 3 specialist review
Open route →
Context lens
Media
Timeline · founder · Phase 1 / 2 / 3 claim boundaries
Open route →09 · Two important but separate Phase 3 questions
Review the case. Advance the assets.
The One-Person Unicorn case and Phase 3 commercial/product advancement are related to the same history, but they do not share the same decision boundary.
One-Person Unicorn Case
A closed Phase 2 provenance question.
Did one person form the eligible Phase 2 asset portfolio inside the bounded period, and does that portfolio have enough substance to justify serious independent review?
- Solo provenance test
- Asset substance test
- Challenges and falsification
- Review can continue in Phase 3 without extending the solo boundary
Phase 3 / Partnership
An open advancement question.
Which program, asset or cluster deserves validation, productization, pilot, licensing, commercialization or partnership now?
- Mazzaneh Re-Launch
- HUAI
- Zoyan
- Standalone asset / cluster routes
09 · Continue
Choose where to go next.
Move directly to the phase, asset family, research route or review system relevant to your question.
Phase 1
Product & Market
Mazzaneh product, market, modules and recognition.
Open → Phase 2AI-Native Formation
Closed solo formation period and technical portfolio roots.
Open → PortfolioSelected Assets
Technical, product, security, research and architecture routes.
Open → ResearchFoundational Research
BioCode, HDTP, ISBP and related research routes.
Open → ReviewReview & Diligence
Phase-aware review, hard questions, provenance and access boundaries.
Open → Phase 3Programs & Partnership
Advance a program, asset or cluster independently or selectively converge.
Open →